Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Coronary insufficiency and beta-blockade.

S H Taylor, B Silke

Journal of Cardiovascular Pharmacology

|January 1, 1985

Summary

This summary is machine-generated.

Beta-blockers effectively treat exercise-induced angina pectoris. However, their long-term benefits and risks in advanced coronary heart disease require further investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Outcomes for Emergency Department Final Diagnosis of Non-specific Complaint compared to Dyspnoea and Pain.

Acute medicine·2024

Same author

Short- and long-term mortality following acute medical admission.

QJM : monthly journal of the Association of Physicians·2023

Same author

Outcomes and Utility of Troponin and NT-proBNP testing in Dyspnoea Presentations.

Irish medical journal·2023

Same author

Blood Culture and Troponin Testing in Suspected Bacteraemic Admissions - Example of Risk Stratification Based on Clinical Testing.

Acute medicine·2023

Same author

The 'Unwell' clinical presentation- an opportunity for admission avoidance?

Acute medicine·2022

Same author

A simple index predicting mortality in acutely hospitalized patients.

QJM : monthly journal of the Association of Physicians·2020

Same journal

Integration of Mendelian Randomization and FAERS Database Analysis Reveals the Association Between Ergotamine and Aortic and Mitral Valve Diseases.

Journal of cardiovascular pharmacology·2026

Same journal

A Comprehensive Review of PCSK9 Inhibitor Therapy.

Journal of cardiovascular pharmacology·2026

Same journal

SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

Journal of cardiovascular pharmacology·2026

Same journal

Aspirin in primary prevention: a case for selective use.

Journal of cardiovascular pharmacology·2026

Same journal

GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease Treatment.

Journal of cardiovascular pharmacology·2026

Same journal

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

Journal of cardiovascular pharmacology·2026

See all related articles

Area of Science:

Cardiology
Pharmacology

Background:

Beta-blocking drugs were initially developed for exercise-induced angina pectoris.
Understanding of coronary insufficiency has evolved significantly since their introduction.

Purpose of the Study:

To review the established and potential therapeutic roles of beta-blockers.
To identify unanswered questions regarding their clinical use, particularly in advanced coronary heart disease.

Main Methods:

Literature review and synthesis of current understanding of beta-blocker pharmacology and clinical application.
Analysis of physiological effects and clinical disadvantages.

Main Results:

Beta-blockers are undoubtedly effective for exercise-induced angina.

Related Experiment Videos

Physiological insights gained from beta-blockers have advanced disease understanding.

Unopposed sympathetic pathways present clinical challenges and disadvantages.

Conclusions:

While effective for specific indications, the long-term benefits and risks of beta-blockers in advanced coronary heart disease remain to be established.
Further research is needed to address remaining clinical questions regarding beta-blocker therapy.